C. S. Ananda Kumar

1.1k total citations
35 papers, 926 citations indexed

About

C. S. Ananda Kumar is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, C. S. Ananda Kumar has authored 35 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 14 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in C. S. Ananda Kumar's work include Synthesis and biological activity (17 papers), Catalytic Cross-Coupling Reactions (4 papers) and Click Chemistry and Applications (4 papers). C. S. Ananda Kumar is often cited by papers focused on Synthesis and biological activity (17 papers), Catalytic Cross-Coupling Reactions (4 papers) and Click Chemistry and Applications (4 papers). C. S. Ananda Kumar collaborates with scholars based in India, Singapore and Australia. C. S. Ananda Kumar's co-authors include Kanchugarakoppal S. Rangappa, S. N. Sridhara, S. Prasad, N. R. Thimmegowda, K. Vinaya, S. Chandrappa, S. Nanjunda Swamy, C. V. Kavitha, Sathees C. Raghavan and K. Muniyappa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Energy and Renewable Energy.

In The Last Decade

C. S. Ananda Kumar

34 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. S. Ananda Kumar India 17 485 250 206 141 78 35 926
Mohammad Bayat Iran 20 1.2k 2.6× 219 0.9× 50 0.2× 45 0.3× 130 1.7× 151 1.6k
Simon Lucas Germany 14 244 0.5× 326 1.3× 131 0.6× 106 0.8× 32 0.4× 27 879
Alexander Barthel Germany 19 197 0.4× 321 1.3× 144 0.7× 57 0.4× 52 0.7× 32 934
Ulf Tilstam United Kingdom 16 649 1.3× 219 0.9× 136 0.7× 30 0.2× 84 1.1× 43 965
Oladapo Bakare United States 16 226 0.5× 194 0.8× 83 0.4× 36 0.3× 48 0.6× 47 573
Moustafa A. Gouda Egypt 25 2.0k 4.0× 328 1.3× 86 0.4× 75 0.5× 102 1.3× 149 2.3k
María T. Baumgartner Argentina 15 352 0.7× 78 0.3× 177 0.9× 96 0.7× 112 1.4× 54 701
Taner Erdoğan Türkiye 10 311 0.6× 102 0.4× 33 0.2× 40 0.3× 31 0.4× 46 479
Eleftherios Halevas Greece 16 163 0.3× 120 0.5× 157 0.8× 84 0.6× 163 2.1× 46 756
Hamida Abdel‐Hamid Egypt 15 487 1.0× 183 0.7× 52 0.3× 14 0.1× 40 0.5× 54 698

Countries citing papers authored by C. S. Ananda Kumar

Since Specialization
Citations

This map shows the geographic impact of C. S. Ananda Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. S. Ananda Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. S. Ananda Kumar more than expected).

Fields of papers citing papers by C. S. Ananda Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. S. Ananda Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. S. Ananda Kumar. The network helps show where C. S. Ananda Kumar may publish in the future.

Co-authorship network of co-authors of C. S. Ananda Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of C. S. Ananda Kumar. A scholar is included among the top collaborators of C. S. Ananda Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. S. Ananda Kumar. C. S. Ananda Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, C. S. Ananda, S. Prasad, M.S. Raghu, et al.. (2023). Design, synthesis, molecular docking and biological evaluation of novel pyrazole derivatives bearing quinoxalinone moiety as multi-targeted anticancer agents. Journal of Molecular Structure. 1288. 135765–135765. 15 indexed citations
2.
Kumar, C. S. Ananda, et al.. (2023). Synthesis of N-Acetyl-3,5-Diaryl-2-pyrazolines from Natural Precursor 2,4,5-Trimethoxy Benzaldehyde (Asaronaldehyde): An Anticancer Studies. Russian Journal of Organic Chemistry. 59(S1). S84–S93.
3.
Chetana, S., et al.. (2022). Study on the DC supply and charging effect on the growth of carbon nanotubes and their electrochemical properties. Journal of Materials Science Materials in Electronics. 33(25). 19937–19946. 3 indexed citations
4.
Shastri, Mahesh, et al.. (2022). Design and Study of Silk Cocoon-ZnO Micro-Nanocomposite based GasSensor for Detection of Flammable Gas at Room Temperature. Asian Journal of Chemistry. 34(5). 1291–1296. 1 indexed citations
5.
Thimmegowda, N. R., Vivek Hamse Kameshwar, B. Sridhar, et al.. (2021). Furan-2-carboxamide derivative, a novel microtubule stabilizing agent induces mitotic arrest and potentiates apoptosis in cancer cells. Bioorganic Chemistry. 108. 104586–104586. 19 indexed citations
8.
Reddy, P. Ravi Kanth, et al.. (2017). CNCPS Fractionations and In-Vitro Nutrient Digestibility of Corn Dried Distiller Grains with Solubles from Various Ethanol Plants in Andhra Pradesh. International Journal of Livestock Research. 1–1. 4 indexed citations
10.
Basappa, Basappa, C. S. Ananda Kumar, S. Nanjunda Swamy, Kazuyuki Sugahara, & Kanchugarakoppal S. Rangappa. (2009). Anti-tumor and anti-angiogenic activity of novel hydantoin derivatives: Inhibition of VEGF secretion in liver metastatic osteosarcoma cells. Bioorganic & Medicinal Chemistry. 17(14). 4928–4934. 42 indexed citations
11.
12.
Kumar, C. S. Ananda, C. V. Kavitha, K. Vinaya, et al.. (2008). Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR study. Investigational New Drugs. 27(4). 327–337. 34 indexed citations
13.
Kumar, C. S. Ananda, S. Prasad, K. Vinaya, et al.. (2008). Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. European Journal of Medicinal Chemistry. 44(3). 1223–1229. 50 indexed citations
14.
Chandrappa, S., S. Prasad, K. Vinaya, et al.. (2008). Synthesis and in vitro antiproliferative activity against human cancer cell lines of novel 5-(4-methyl-benzylidene)-thiazolidine-2,4-diones. Investigational New Drugs. 26(5). 437–444. 53 indexed citations
15.
Prasad, S., K. Vinaya, C. S. Ananda Kumar, Sanjay Swarup, & Kanchugarakoppal S. Rangappa. (2008). Synthesis of novel 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole derivatives as antiproliferative agents: A structure–activity relationship study. Investigational New Drugs. 27(6). 534–542. 17 indexed citations
16.
Malviya, Manish, Joya Chandra, C. T. Sadashiva, et al.. (2008). Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer’s dementia models. Bioorganic & Medicinal Chemistry. 16(9). 5157–5163. 17 indexed citations
17.
Kavitha, C. V., Mridula Nambiar, C. S. Ananda Kumar, et al.. (2008). Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochemical Pharmacology. 77(3). 348–363. 129 indexed citations
18.
Thimmegowda, N. R., S. Nanjunda Swamy, C. S. Ananda Kumar, et al.. (2007). Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation. Bioorganic & Medicinal Chemistry Letters. 18(1). 432–435. 51 indexed citations
19.
Sharada, A. C., et al.. (2007). In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor. Bioorganic & Medicinal Chemistry. 15(24). 7696–7703. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026